Inhibitory effect of novel Eugenol Tosylate Congeners on pathogenicity of Candida albicans
Abstract Background The global prevalence of fungal diseases is increasing rapidly, which affects more than a billion people every year with significant mortality rate. On the other hand, the development of new drugs to treat these fungal infections is slow, while the current antifungal therapy is i...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | BMC Complementary Medicine and Therapies |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12906-020-02929-0 |